耗材描述

• 分子式 C₂₀H₂₃BCl₂N₂O₉
• 分子量517.12

属性

溶解性	DMSO 103 mg/mL Water <1 mg/mL Ethanol <1 mg/mL
存贮条件	储存温度-20°C

描述

产品介绍	MLN9708 immediately hydrolyzed to MLN2238, the biologically active form, on exposure to aqueous solutions or plasma. MLN2238 inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50/Ki of 3.4 nM/0.93 nM.
备注	MLN9708 immediately hydrolyzed to MLN2238, the biologically active form, on exposure to aqueous solutions or plasma. MLN2238 inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50/Ki of 3.4 nM/0.93 nM
生化机理	MLN9708 immediately hydrolyzed to MLN2238, which is an N-capped dipeptidyl leucine boronic acid and preferentially bound to and inhibited the 20S proteasome with an IC50 value of 3.4 nM (Ki = 0.93 nM).
别名	4-羧基-2-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]-6-氧代-1,3,2-二氧硼杂环己-4-乙酸; MLN 9708; MLN-9708;Ixazomib; MLN 9708; MLN-9708;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid

猜你喜欢

• 

  硫酸酯酶 from Helix pomatia Type H-2， aqueous solution， ≥2，000 units/mL

• 

  胰蛋白酶 来源于猪胰腺

• 

  胆固醇氧化酶，， ≥50 units/mg蛋白质

• 

  MK-0752

• 

  兔肌动蛋白，85+%

• 

  Bortezomib (PS-341)

• 

  半乳糖脱氢酶/半乳糖变旋酶，来源于，EC:1.1.1.48+5.1.3.3

• 

  过氧化酶，提取自辣根，冻干粉，50~150UI/mg （氧化剂）

• 

  1,3-β-D-葡聚糖外切酶，来源于Trichoderma virens Recombinant，EC:3.2.1.58

• 

  384 AMPLIFICATION PLATE, WHITE

感兴趣产品

• MLN9708价格
• MLN9708厂商
• MLN9708规格